Ukuhlolwa Okusheshayo kwe-SARS-CoV-2 IgG/IgM
-
Ukuhlolwa Okusheshayo kwe-SARS-CoV-2 IgM/IgG Antibody
REF 502090 Ukucaciswa 20 Izivivinyo/Ibhokisi Umgomo wokutholwa Ukuhlolwa kwe-Immunochromatographic Izibonelo Igazi Eliphelele / I-Serum / Plasma Ukusetshenziswa Okuhlosiwe Lokhu ukuhlola okusheshayo kwe-immuno-chromatographic kokutholwa ngasikhathi sinye kwamasosha omzimba e-IgM ne-IgG kugciwane le-SARS-CoV-2 egazini lomuntu lonke, i-serum noma i-plasma. Ukuhlola kukhawulelwe e-US ukuthi kusakazwe ezindaweni zokucwaninga ezigunyazwe yi-CLIA ukuze zenze ukuhlola okuyinkimbinkimbi.
Lokhu kuhlolwa akuzange kubuyekezwe yi-FDA.
Imiphumela engemihle ayikuvimbeli ukutheleleka okukhulu kwe-SARS-CoV-2.
Imiphumela yokuhlolwa kwe-antibody akufanele isetshenziselwe ukuxilonga noma ukukhipha ukutheleleka kwe-SARS-CoV-2 okuyingozi.
Imiphumela emihle ingase ibe ngenxa yokutheleleka kwangaphambilini noma kwamanje ngezinhlobo ze-coronavirus ezingezona ze-SARS-CoV-2, njenge-coronavirus HKU1, NL63, OC43, noma 229E.
